NeuClone Mission
NeuClone is dedicated to scientific integrity in cell line engineering for the safe and cost effective production of biological drugs and endeavors to be the trusted supplier of superior CHO cell lines for the biomanufacturing industry.
Product Catalogue
NeuClone is developing CHO cell lines that produce recombinant proteins for the treatment of human diseases such as cancer and autoimmune disorders.
Employment
NeuClone is seeking skilled scientists with expertise in cell line development...
NeuClone is a biotech company specializing in cell line engineering for the biopharmaceutical and biomanufacturing industries.
NeuClone has developed a platform technology for the commercial production of protein therapeutics. The platform consists of :
1) a proprietary Chinese hamster ovary (CHO) cell line with superior growth properties and production capabilities, named NeuCHO,
2) DNA expression vectors designed for high-level expression of single chain proteins and monoclonal antibodies (Mabs), and
3) a growing portfolio of engineered cell lines that are expressing biosimilars.
NeuClone's cell lines secreting various biosimilars are available for licensing.






